These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16925744)

  • 41. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
    Loran OB; Fedorova NV; Mazurenko DA; Khitarishvili EV
    Urologiia; 2006; (2):37-9, 41. PubMed ID: 16708587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxybutynin in detrusor overactivity.
    Diokno A; Ingber M
    Urol Clin North Am; 2006 Nov; 33(4):439-45, vii. PubMed ID: 17011379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
    Serati M; Salvatore S; Uccella S; Cromi A; Khullar V; Cardozo L; Bolis P
    Eur Urol; 2008 Oct; 54(4):911-5. PubMed ID: 18036728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder.
    Ko Y; Malone DC; Armstrong EP
    Pharmacotherapy; 2006 Dec; 26(12):1694-702. PubMed ID: 17125433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus.
    Sakakibara R; Kanda T; Sekido T; Uchiyama T; Awa Y; Ito T; Liu Z; Yamamoto T; Yamanishi T; Yuasa T; Shirai K; Hattori T
    Neurourol Urodyn; 2008; 27(6):507-10. PubMed ID: 18092331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of persistent detrusor overactivity after transvaginal sling procedures.
    Gamble TL; Botros SM; Beaumont JL; Goldberg RP; Miller JJ; Adeyanju O; Sand PK
    Am J Obstet Gynecol; 2008 Dec; 199(6):696.e1-7. PubMed ID: 18845297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
    Ronchi P; Gravina GL; Galatioto GP; Costa AM; Martella O; Vicentini C
    Neurourol Urodyn; 2009; 28(1):52-7. PubMed ID: 18671288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
    Nishiguchi J; Kwon DD; Kaiho Y; Chancellor MB; Kumon H; Snyder PB; Yoshimura N
    BJU Int; 2007 Mar; 99(3):680-6. PubMed ID: 17155980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination drug therapy improves compliance of the neurogenic bladder.
    Cameron AP; Clemens JQ; Latini JM; McGuire EJ
    J Urol; 2009 Sep; 182(3):1062-7. PubMed ID: 19616807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Damage to the bladder neck alters autonomous activity and its sensitivity to cholinergic agonists.
    de Jongh R; van Koeveringe GA; van Kerrebroeck PE; Markerink-van Ittersum M; de Vente J; Gillespie JI
    BJU Int; 2007 Oct; 100(4):919-29. PubMed ID: 17822470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Overactive bladder--treatment with antimuscarinic agents].
    Höfner K
    Urologe A; 2003 Jun; 42(6):793-800. PubMed ID: 12851770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urge incontinence.
    Moen M; Stien R
    Ann Chir Gynaecol; 1982; 71(4):203-7. PubMed ID: 6889832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detrusor underactivity following laparoscopic radical prostatectomy].
    Ishida Y; Matsukawa Y; Komatsu T; Yoshikawa Y; Hattori R; Goton M
    Hinyokika Kiyo; 2008 Apr; 54(4):257-60. PubMed ID: 18516916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
    Morris AR; O'Sullivan R; Dunkley P; Moore KH
    Eur Urol; 2007 Sep; 52(3):876-81. PubMed ID: 17335962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Drinka PJ
    J Am Geriatr Soc; 2006 Jun; 54(6):1004-5. PubMed ID: 16776800
    [No Abstract]   [Full Text] [Related]  

  • 57. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
    Kuo HC
    Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.
    Bael A; Lax H; de Jong TP; Hoebeke P; Nijman RJ; Sixt R; Verhulst J; Hirche H; van Gool JD;
    J Urol; 2008 Oct; 180(4):1486-93; discussion 1494-5. PubMed ID: 18710726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging bladder sensations.
    Griffiths D
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):899-903. PubMed ID: 17654564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.